Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 6, 2007, Pages 2205-2207

  Könönen, Eija ^a   Bryk, Anne ^a   Niemi, Päivi ^b   Kanervo Nordström, Arja ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Kymenlaakson Sairaanhoitopiiri   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAMASE; CEFOXITIN; CLINDAMYCIN; ERTAPENEM; METRONIDAZOLE; MOXIFLOXACIN;

ANAEROBIC INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTOSTREPTOCOCCUS; PEPTOSTREPTOCOCCUS ANAEROBIUS; PEPTOSTREPTOCOCCUS STOMATIS; PRIORITY JOURNAL;

ANAEROBIOSIS; ANTI-BACTERIAL AGENTS; BACTEREMIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTOSTREPTOCOCCUS; SPECIES SPECIFICITY;

EID: 34250155293     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00056-07     Document Type: Article

References (28)

1. Ackermann, G., R. Schaumann, B. Pless, M. Claros, E. J. C. Goldstein, and A. C. Rodloff. 2000. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 19:228-232.
2. Aldridge, K. E., C. V. Sanders, A. C. Lewis, and R. L. Marier. 1983. Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production. J. Med. Microbiol. 16:75-82.
3. Benson, D. A., I. Karsch-Mizrachi, D. J. Lipman, J. Ostell, and D. L. Wheeler. 2006. GenBank. Nucleic Acids Res. 34:D16-D20.
4. Brazier, J. S., V. Hall, T. E. Morris, M. Gal, and B. I. Duerden. 2003. Antibiotic susceptibilities of gram-positive anaerobic cocci: results of a sentinel study in England and Wales. J. Antimicrob. Chemother. 52:224-228.
5. Brook, I. 1988. Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitals. J. Clin. Microbiol. 26:1181-1188.
6. Brook, I. 1994. Peptostreptococcal infection in children. Scand. J. Infect. Dis. 26:503-510.
7. Clinical Laboratory Standards Institute. 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard-7th ed. M11-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Cone, L. A., B. A. Battista, and C. W. Shaeffer, Jr. 2003. Endocarditis due to Peptostreptococcus anaerobius: case report and literature review of peptostreptococcal endocarditis. J. Heart Valve Dis. 12:411-413.
9. Downes, J., and W. G. Wade. 2006. Peptostreptococcus stomatis sp. nov., isolated from the human oral cavity. Int. J. Syst. Evol. Microbiol. 56:751-754.
10. Ezaki, T., Y. Kawamura, N. Li, Z. Y. Li, L. Zhao, and S. Shu. 2001. Proposal of the genera Anaerococcus gen. nov., Peptoniphilus gen. nov. and Gallicola gen. nov. for members of the genus Peptostreptococcus. Int. J. Syst. Evol. Microbiol. 51:1521-1528.
11. Finegold, S. M., Y. Song, and C. Liu. 2002. General comments and update on taxonomy of Clostridia and anaerobic cocci. Anaerobe 8:283-285.
12. Finegold, S. M., Y. Song, C. Liu, D. W. Hecht, P. Summanen, E. Kononen, and S. D. Allen. 2005. Clostridium clostridioforme: a mixture of three clinically important species. Eur. J. Clin. Microbiol. Infect. Dis. 24:319-324.
13. Hecht, D. W., and J. R. Osmolski. 2003. Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates. Antimicrob. Agents Chemother. 47:910-916.
14. Hoellman, D. B., L. M. Kelly, K. Credito, L. Anthony, L. M. Ednie, M. R. Jacobs, and P. C. Appelbaum. 2002. In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds. Antimicrob. Agents Chemother. 46:220-224.
15. Jalava, J., and E. Eerola. 1999. Phylogenetic analysis of Fusobacterium alocis and Fusobacterium sulci based on 16S rRNA gene sequences: proposal of Filifactor alocis (Cato, Moore and Moore) comb. nov. and Eubacterium sulci (Cato, Moore and Moore) comb. nov. Int. J. Syst. Bacteriol. 49:1375-1379.
16. Jousimies-Somer, H. R., P. Summanen, D. M. Citron, E. J. Baron, H. M. Wexler, and S. M. Finegold. 2002. Wadsworth-KTL anaerobic bacteriology manual, 6th ed. Star Publishing, Belmont, CA.
17. Koeth, L. M., C. E. Good, P. C. Appelbaum, E. J. C. Goldstein, A. C. Rodloff, M. Claros, and L. J. Dubreuil. 2004. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents. J. Antimicrob. Chemother. 53:1039-1044.
18. Lubbe, M. M., P. L. Botha, and L. J. Chalkley. 1999. Comparative activity of eighteen antimicrobial agents against anaerobic bacteria isolated in South Africa. Eur. J. Clin. Microbiol. Infect. Dis. 18:46-54.
19. Murdoch, D. A. 1998. gram-positive anaerobic cocci. Clin. Microbiol. Rev. 11:81-120.
20. Murdoch, D. A., I. J. Mitchelmore, and S. Tabaqchali. 1994. The clinical importance of gram-positive anaerobic cocci isolated at St. Bartholomew's Hospital, London, in 1987. J. Med. Microbiol. 41:36-44.
21. Reig, M., and F. Baquero. 1994. Antimicrobial activity of clavulanate and tazobactam on Peptostreptococcus spp. J. Antimicrob. Chemother. 33:358-359.
22. Riggio, M. P., and A. Lennon. 2002. Development of a PCR assay specific for Peptostreptococcus anaerobius. J. Med. Microbiol. 51:1097-1101.
23. Roberts, S. A., K. P. Shore, S. D. Paviour, D. Holland, and A. J. Morris. 2006. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003. J. Antimicrob. Chemother. 57:992-998.
24. Smith, A. J., V. Hall, B. Thakker, and C. G. Gemmell. 2005. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J. Antimicrob. Chemother. 56:407-409.
25. Song, Y., C. Liu, and S. M. Finegold. 2007. Development of a flow chart for identification of gram-positive anaerobic cocci (GPAC) in the clinical laboratory. J. Clin. Microbiol. 45:512-516.
26. Theron, M. M., M. N. Janse van Rensburg, and L. J. Chalkley. 2004. Nitroimidazole resistance genes (nimB) in anaerobic gram-positive cocci (previously Peptostreptococcus spp.). J. Antimicrob. Chemother. 54:240-242.
27. Tyrrell, K. L., D. M. Citron, Y. A. Warren, S. Nachnani, and E. J. C. Goldstein. 2003. Anaerobic bacteria cultured from the tongue dorsum of subjects with oral malodor. Anaerobe 9:243-246.
28. Wren, M. W. D. 1996. Anaerobic cocci of clinical importance. Br. J. Biomed. Sci. 53:294-301.